Eris Lifesciences Ltd Q1FY2023 consolidated net profit up QoQ at Rs. 94.57 crores

Eris Lifesciences Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 401.321 crores during the period ended June 30, 2022 as compared to Rs. 314.010 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 94.577 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 80.296 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 6.95 for the period ended June 30, 2022 as compared to Rs. 5.91 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 401.321 crs	₹314.010 crs	27.81%
Net Profit	₹94.577 crs	₹80.296 crs	17.79%
EPS	₹6.95	₹5.91	17.60%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 401.321 crores during the period ended June 30, 2022 as compared to Rs.355.135 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.94.577 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.106.659 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.6.95 for the period ended June 30, 2022 as compared to Rs.7.85 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 401.321 crs	₹355.135 crs	13.01%
Net Profit	₹94.577 crs	₹106.659 crs	-11.33%
EPS	₹6.95	₹7.85	-11.46%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 696.65 as compared to the previous close of Rs. 704.35. The total number of shares traded during the day was 2205 in over 803 trades.

The stock hit an intraday high of Rs. 713.70 and intraday low of 686.90. The net turnover during the day was Rs. 1546461.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q1FY23 ResultUpdate